Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.